Ashutosh Sharma
Corporate Officer/Principal presso New Jersey Institute of Technology
Profilo
Ashutosh Sharma is Vice President of Product and Process Development for Vyteris Holdings, Inc. Previously, he was Program Manager of Becton Dickinson.
Dr. Sharma received an MD from Rensselaer Polytechnic Institute and a Bachelor's degree from the Indian Institute of Technology in Kanpur, India.
Posizioni attive di Ashutosh Sharma
| Società | Posizione | Inizio |
|---|---|---|
| New Jersey Institute of Technology | Corporate Officer/Principal | - |
Precedenti posizioni note di Ashutosh Sharma
| Società | Posizione | Fine |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Corporate Officer/Principal | - |
Formazione di Ashutosh Sharma
| Rensselaer Polytechnic Institute | Doctorate Degree |
| Indian Institute of Technology Kharagpur | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
- Borsa valori
- Insiders
- Ashutosh Sharma
